Table 1

Comercial sources, clones, and working dilutions of antibodies used in this case
Antibody Dilution Clone Vendor
HMWK Ready to use 34 βE12 Novocastra, New Castle, UK
EMA Ready to use GP1.4 Novocastra, New Castle, UK
CK Ready to use AE1/AE3 Novocastra, New Castle, UK
CK20 Ready to use PW31 Novocastra, New Castle, UK
CDX-2 1: 100 AMT28 Novocastra, New Castle, UK
CK7 Ready to use RN7 Novocastra, New Castle, UK
CD5 Ready to use 4C7 Novocastra, New Castle, UK
Villin 1: 200 CWWB1 Novocastra, New Castle, UK
MOC31 1: 50 MOC31 Novocastra, New Castle, UK
ER Ready to use 6 F11 Novocastra, New Castle, UK
PR Ready to use 16 Novocastra, New Castle, UK
TTF-1 1: 200 SPT24 Novocastra, New Castle, UK
GCDFP-15 Ready to use 23A3 Novocastra, New Castle, UK
P63 1: 25 7JUL Novocastra, New Castle, UK
CD30 Ready to use JCM182 Novocastra, New Castle, UK
PLAP Ready to use 8A9 Novocastra, New Castle, UK
Chromogranin Ready to use 5H7 Novocastra, New Castle, UK
CD117 Ready to use T595 Novocastra, New Castle, UK
Calretinin 1: 200 CAL6 Novocastra, New Castle, UK

Maghbool et al.

Maghbool et al. BMC Clinical Pathology 2013 13:17   doi:10.1186/1472-6890-13-17

Open Data